Garren, Nancy External Entity

Publications

Sort by

Selected publications

  • Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma.  Journal of clinical oncology : official journal of the American Society of Clinical Oncology2009 Academic Article GET IT

Other